Evidence map›Paper›PMID 33030683›Full record

ReviewCurrent osteoporosis reports2020

The Gut Microbiome and Bone Strength.

Macy Castaneda, Jasmin M Strong, Denise A Alabi, Christopher J Hernandez

Abstract readReview
In one paragraph

Review in Current osteoporosis reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Role of vitamins in the development and treatment of osteoporosis (Review).International journal of molecular medicine · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. A Pilot Study of the Gut Microbiota in Spine Fusion Surgery Patients.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025
    Article
  12. Review
  13. Review
  14. Microbiome-induced increases and decreases in bone matrix strength can be initiated after skeletal maturity.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Macy CastanedaSibley School of Mechanical and Aerospace Engineering, Cornell University, 124 Hoy Road, 355 Upson Hall, Ithaca, NY, 14850, USA.
Jasmin M StrongSibley School of Mechanical and Aerospace Engineering, Cornell University, 124 Hoy Road, 355 Upson Hall, Ithaca, NY, 14850, USA.
Denise A AlabiSibley School of Mechanical and Aerospace Engineering, Cornell University, 124 Hoy Road, 355 Upson Hall, Ithaca, NY, 14850, USA.
Christopher J HernandezSibley School of Mechanical and Aerospace Engineering, Cornell University, 124 Hoy Road, 355 Upson Hall, Ithaca, NY, 14850, USA. cjh275@cornell.edu.ORCID 0000-0002-0712-6533

Funding

The Microbiome and Bone StrengthR01AG067997 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HERNANDEZ, CHRISTOPHER JOHN · 2021 to 2025
$3.2M
The Microbiome and Bone StrengthR56AG067997 · NIA · CORNELL UNIVERSITY · PI HERNANDEZ, CHRISTOPHER JOHN · 2020 to 2020
$597k
The microbiome as a risk factor for periprosthetic joint infectionR21AR071534 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI BOSTROM, MATHIAS P., HERNANDEZ, CHRISTOPHER JOHN · 2017 to 2018
$431k
The Role of Bone Resorption in Bone Marrow LesionsR21AR073454 · NIAMS · CORNELL UNIVERSITY · PI HERNANDEZ, CHRISTOPHER JOHN · 2018 to 2019
$407k
Separating Systemic Inflammation From Obesity in Load-Induced OsteoarthritisR21AR068061 · NIAMS · CORNELL UNIVERSITY · PI HERNANDEZ, CHRISTOPHER JOHN · 2015 to 2016
$371k
NIAMS NIH HHS R21 AR068061NIAMS NIH HHS R21 AR071534NIAMS NIH HHS R21 AR073454NIA NIH HHS R01 AG067997NIA NIH HHS R56 AG067997
6 · The paper itself

Abstract

purpose of reviewOsteoporosis is commonly diagnosed through the clinical assessment of bone quantity using bone mineral density; however, the primary clinical concern is bone fragility. Bone fragility is determined by both bone quantity and bone quality. Over the past decade, the gut microbiome has emerged as a factor that can regulate diseases throughout the body. This review discusses how microbial organisms and their genetic products that inhabit the gastrointestinal tract influence bone quantity, bone quality, and bone strength. RECENT

findingsRecent studies have shown that the gut microbiome regulates bone loss during estrogen depletion and glucocorticoid treatment. A series of studies has also shown that the gut microbiome influences whole bone strength by modifying bone tissue quality. The possible links between the gut microbiome and bone tissue quality are discussed focusing on the effects of microbiome-derived vitamin K. We provide a brief introduction to the gut microbiome and how modifications to the gut microbiome may lead to changes in bone. The gut microbiome is a promising target for new therapeutic approaches that address bone quality in ways not possible with current interventions.

Indexed as

AnimalsBone and BonesBone DensityGastrointestinal MicrobiomeHumansOsteoporosisBone material propertiesBone qualityBone quantityGut microbiomeVitamin K

Identifiers

PMID33030683
PMCPMC7736097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.